Grants for Public and State controlled institutions of higher education - Federal

This grant provides funding for innovative research projects that aim to transform manufacturing processes in the U.S. by addressing scientific, technological, and educational challenges, while promoting workforce development and inclusivity in STEM fields.

This funding opportunity is designed to support research and development projects that advance clean hydrogen and fuel cell technologies, particularly for heavy-duty transportation and industrial applications, while promoting equity and community benefits.

This funding opportunity provides financial support to state and local governments, Tribal entities, educational institutions, and non-profit organizations for projects that enhance wildlife habitats, improve migration corridors, and promote climate resilience on public lands in Idaho.

This funding opportunity provides financial support for eligible organizations to research and analyze the incidence of epilepsy among children in the U.S., focusing on disparities and risk factors using advanced data science techniques.

This funding opportunity provides financial support to a wide range of organizations, including government entities and nonprofits, to help the Government of Kenya strengthen and sustain its HIV prevention and treatment programs as part of a national health strategy.

This funding opportunity supports higher education institutions in training researchers, particularly those from underrepresented groups, to improve community living and participation outcomes for people with disabilities.

This funding opportunity supports research and innovation projects that foster collaboration among nonprofit organizations and educational institutions in the U.S., Bahrain, and the U.K. to advance technology and economic partnerships.

The National Park Service (NPS), the Department of Defense, Defense Health Agency (DoD) have a partnership focused on promoting the health and wellness of active-duty military service members and their families through positive engagement experiences with national parks, public lands, and waterways. These experiences will promote healthy lifestyle habits and inspire families to become environmental stewards of national parks.

The "Neuromodulation/Neurostimulation Device Development for Mental Health Applications" grant aims to fund the development of innovative brain stimulation devices or significant hardware/software enhancements to existing FDA-approved devices, with a focus on improving precision and delivery, for the treatment of mental health disorders.

The IRACDA program is a grant that supports postdoctoral research and teaching development, aiming to diversify the biomedical research workforce by fostering partnerships between research-intensive and teaching-intensive institutions, and providing opportunities for underrepresented groups, while also enhancing science education and research methods at partner institutions.

This grant provides funding to partnerships of employers, educational institutions, and community organizations to develop cybersecurity workforce training programs that address local labor market needs.

This funding opportunity supports academic institutions in the Gulf of America region to conduct interdisciplinary research on climate adaptation, coastal resilience, and ecosystem management in collaboration with NOAA.

This funding opportunity supports U.S. institutions and organizations in developing animal models and biological resources to advance research on Down syndrome and its related health conditions.

This funding opportunity supports U.S.-based institutions in enhancing the accessibility and usability of planetary science data through archiving, restoration, and tool development, with provisions for international participation.

This program provides funding to researchers and organizations to develop innovative technologies that improve teamwork between humans and intelligent agents in military operations.

This funding opportunity provides support for the ongoing development and maintenance of valuable informatics tools and resources that enhance cancer research and management, benefiting researchers and the broader cancer community.

The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. Section I. Funding Opportunity Description The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. NIH Institutes and Centers (ICs) support a variety of mentored and non-mentored career development award programs designed to foster the transition of new investigators to research independence and to support established investigators in achieving specific objectives. Candidates should review the different career development (K) award programs to determine the best program to support their goals. More information about Career programs may be found at the NIH Extramural Training Mechanisms website. The NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is designed to enable mid-career clinician-scientists to: Devote more time to augment their capabilities in Patient-Oriented Research (POR); and Provide mentoring to junior clinical investigators in the conduct of POR (see below for definition). The K24 award is intended to provide protected time to mid-career clinical investigators to provide mentoring to junior clinical investigators, particularly K23 grantees, in POR and to stabilize the careers of these investigators. The intent is to allow these investigators to continue to conduct POR and be available as mentors in POR. It is expected that K24 recipients will obtain new or additional independent, peer-reviewed funding for POR as PD/PI and establish and assume leadership roles in collaborative POR programs. In addition, it is expected that there will be an increased effort and commitment to act as a mentor to beginning clinician investigators in POR to enhance the research productivity of both the K24 investigator and increase the pool of well-trained clinical researchers of the future. For the purposes of the K24 award, Patient-Oriented Research is defined as research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. This area of research includes: (1) mechanisms of human disease; (2) therapeutic interventions; (3) clinical trials, and; (4) the development of new technologies. Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, patient-oriented research is research in which it is necessary to know the identity of the patients from whom the cells or tissues under study are derived. Studies falling under Exemption 4 for human subjects research are not included in this definition. See also the NIH Director's Panel on Clinical Research Report. NIH defines a clinical trial as "A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes." (NOT-OD-15-015). NIH not only supports trials of safety and efficacy, it also supports mechanistic exploratory studies that meet the definition of a clinical trial and are designed to explore or understand a biological or behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention. These studies may focus on basic and/or translational discovery research in healthy human subjects and in human subjects who are affected by the pathophysiology of diseases and disorders. By addressing basic questions and concepts in biology, behavior, and pathophysiology, these studies may provide insight into understanding human diseases and disorders along with potential treatments or preventive strategies. NIH also supports biomarker studies that meet the definition of a clinical trial and that may provide information about physiological function, target engagement of novel therapeutics, and/or the impact of therapeutics on treatment response. NIH thus supports studies that meet the definition of clinical trials (as noted above) but do not seek to establish safety, clinical efficacy, effectiveness, clinical management, and/or implementation of preventive, therapeutic, and services interventions. Note: This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA Special Note: Because of the differences in individual Institute and Center (IC) program requirements for this FOA, prospective candidates are strongly encouraged to consult the Table of IC-Specific Information, Requirements and Staff Contacts, to make sure that their application is appropriate for the requirements of one of the participating NIH ICs. See Section VIII. Other Information for award authorities and regulations. Section II. Award Information Funding Instrument Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. Application Types Allowed New Resubmission Revision Renewal The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA. Clinical Trial? Required: Only accepting applications that propose an independent clinical trial(s) Need help determining whether you are doing a clinical trial? Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Award Budget Award budgets are composed of salary and other program-related expenses, as described below. Award Project Period The total project period may not exceed 5 years.

This grant seeks to foster collaborative research partnerships between U.S.-based universities, research institutions, and the Army to accelerate the development and integration of advanced technologies for national defense.

This funding opportunity supports innovative research projects aimed at advancing the understanding, detection, and treatment of ovarian cancer, targeting early-stage investigators and institutions involved in non-clinical research.

This funding opportunity provides financial support for organizations to implement and evaluate innovative anti-trafficking interventions globally, focusing on prevention, protection, prosecution, and partnerships to combat human trafficking.